WO2007065024A3 - Composition and use of phyto-percolate for treatment of disease - Google Patents

Composition and use of phyto-percolate for treatment of disease Download PDF

Info

Publication number
WO2007065024A3
WO2007065024A3 PCT/US2006/046320 US2006046320W WO2007065024A3 WO 2007065024 A3 WO2007065024 A3 WO 2007065024A3 US 2006046320 W US2006046320 W US 2006046320W WO 2007065024 A3 WO2007065024 A3 WO 2007065024A3
Authority
WO
WIPO (PCT)
Prior art keywords
phyto
percolate
disease
treatment
composition
Prior art date
Application number
PCT/US2006/046320
Other languages
French (fr)
Other versions
WO2007065024A2 (en
Inventor
Tiffany Thomas
Original Assignee
Health Enhancement Products In
Tiffany Thomas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Enhancement Products In, Tiffany Thomas filed Critical Health Enhancement Products In
Priority to AU2006320264A priority Critical patent/AU2006320264A1/en
Priority to JP2008543545A priority patent/JP2009518312A/en
Priority to EP06838974A priority patent/EP1954800A4/en
Priority to CA2631773A priority patent/CA2631773C/en
Publication of WO2007065024A2 publication Critical patent/WO2007065024A2/en
Publication of WO2007065024A3 publication Critical patent/WO2007065024A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The phyto-percolate is believed to contain an enzyme having proteolytic activity. The invention further relates to the use of the phyto-percolate in a variety of disease states.
PCT/US2006/046320 2005-04-20 2006-12-04 Composition and use of phyto-percolate for treatment of disease WO2007065024A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2006320264A AU2006320264A1 (en) 2005-04-20 2006-12-04 Composition and use of phyto-percolate for treatment of disease
JP2008543545A JP2009518312A (en) 2005-12-02 2006-12-04 Compositions and uses of plant exudates for treating diseases
EP06838974A EP1954800A4 (en) 2005-12-02 2006-12-04 Composition and use of phyto-percolate for treatment of disease
CA2631773A CA2631773C (en) 2005-12-02 2006-12-04 Composition and use of phyto-percolate for treatment of disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74177405P 2005-12-02 2005-12-02
US60/741,774 2005-12-02

Publications (2)

Publication Number Publication Date
WO2007065024A2 WO2007065024A2 (en) 2007-06-07
WO2007065024A3 true WO2007065024A3 (en) 2008-01-10

Family

ID=38092904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/046320 WO2007065024A2 (en) 2005-04-20 2006-12-04 Composition and use of phyto-percolate for treatment of disease

Country Status (5)

Country Link
EP (1) EP1954800A4 (en)
JP (1) JP2009518312A (en)
AU (1) AU2006320264A1 (en)
CA (1) CA2631773C (en)
WO (1) WO2007065024A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807622B2 (en) 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US8586053B2 (en) 2005-09-21 2013-11-19 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
CA2780144A1 (en) * 2009-11-16 2011-05-19 Health Enhancement Products, Inc. Use of an extract derived from atcc #pta-5863 as an anti-inflammatory and anti-viral agent
JP2013520444A (en) 2010-02-22 2013-06-06 ヘルス エンハンスメント プロダクツ インコーポレイテッド Drugs and mechanisms for treating hypercholesterolemia
WO2014167326A1 (en) * 2013-04-09 2014-10-16 Cresset Biomolecular Discovery Ltd The local treatment of inflammatory ophthalmic diseases
WO2014201372A1 (en) 2013-06-13 2014-12-18 Health Enhancement Products, Inc. Compounds and methods for affecting cytokines
CA3011687A1 (en) 2015-02-16 2016-08-25 Zivo Bioscience, Inc. Methods of modulating immune and inflammatory responses via administration of an algal biomass
WO2017142906A1 (en) 2016-02-16 2017-08-24 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152587A1 (en) * 2000-08-10 2003-08-14 Kralovec Jaroslav A. Methods for making and using a Chlorella extract having immunomodulating properties
WO2005112987A2 (en) * 2004-04-23 2005-12-01 Health Enhancement Products, Inc. Method of preparation and use of fibrinolytic enzymes in the treatment of disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152587A1 (en) * 2000-08-10 2003-08-14 Kralovec Jaroslav A. Methods for making and using a Chlorella extract having immunomodulating properties
WO2005112987A2 (en) * 2004-04-23 2005-12-01 Health Enhancement Products, Inc. Method of preparation and use of fibrinolytic enzymes in the treatment of disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIM ET AL.: "Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. strain CK 11-4 screened from Chungkook-Jang", APPL. ENVIRON. MICROBIOLOGY, vol. 62, no. 7, July 1996 (1996-07-01), pages 2482 - 2488, XP007908743 *

Also Published As

Publication number Publication date
CA2631773A1 (en) 2007-06-07
JP2009518312A (en) 2009-05-07
WO2007065024A2 (en) 2007-06-07
EP1954800A4 (en) 2010-03-03
CA2631773C (en) 2022-04-26
EP1954800A2 (en) 2008-08-13
AU2006320264A1 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
WO2007065024A3 (en) Composition and use of phyto-percolate for treatment of disease
WO2005112987A3 (en) Method of preparation and use of fibrinolytic enzymes in the treatment of disease
WO2008063382A3 (en) Antagonists of pcsk9
WO2008133647A3 (en) Antagonists of pcsk9
WO2006029183A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
WO2006026617A3 (en) Compositions and methods of promoting hair growth
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2011053783A3 (en) Ax213 and ax132 pcsk9 antagonists and variants
WO2005077093A3 (en) Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
WO2005105780A3 (en) Compositions useful as inhibitors of rock and other protein kinases
WO2005103050A3 (en) Azaindoles useful as inhibitors of rock and other protein kinases
WO2006113925A3 (en) Composition and use of phyto-percolate for treatment of disease
SG151327A1 (en) Deazapurines useful as inhibitors of janus kinases
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
HK1113569A1 (en) Pyrazolo
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005112981A3 (en) Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
WO2005113752A3 (en) Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
WO2005000860A3 (en) Compositions and methods for treatment of disease with acetylated disaccharides
WO2012073192A3 (en) Mixed fatty acid soap/fatty acid insecticidal, cleaning and antimicrobial compositions
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
WO2007002837A3 (en) Methods and compositions for the prevention and treatement of inflammatory disease
WO2006081516A3 (en) USE OF BAFF TO TREAT Th2-MEDIATED CONDITIONS

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2008543545

Country of ref document: JP

Ref document number: 2631773

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006838974

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006320264

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006320264

Country of ref document: AU

Date of ref document: 20061204

Kind code of ref document: A